Mus vs Oman: HIV-positive TB patients on CPT (co-trimoxazole preventive therapy)
Mus
100.0%
in 2014
Oman
100.0%
in 2014
Mus rank
1st
Oman rank
1st
HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) over time
- Mus
- Oman
How they compare
Mus currently reports 100.0% against 100.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2005 it was Oman ahead.
Mus ranks 1st and Oman ranks 1st of 2 regions.
Across the 2 decades both report, Mus averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Mus | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 86.0% | 100.0% | 14.0% | Oman |
| 2010s | 100.0% | 97.6% | 2.4% | Mus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on cpt (co-trimoxazole preventive therapy), Mus or Oman?
- Mus, at 100.0% against 100.0% in Oman as of 2014.
- What is the difference in hiv-positive tb patients on cpt (co-trimoxazole preventive therapy) between Mus and Oman?
- 0.0%, with Mus ahead.
- How many years of comparable data are there for Mus and Oman?
- 10 years are reported by both, from 2005 to 2014.
- How do Mus and Oman rank globally for hiv-positive tb patients on cpt (co-trimoxazole preventive therapy)?
- Mus ranks 1st and Oman ranks 1st of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.